Guyana

Reimbursed Care Access

Guyana maintains a strict national control regime for most classical and novel psychedelic compounds under its Narcotic Drugs and Psychotropic Substances (Control) legislation and subsequent amendments; non‑medical possession and trafficking are criminal offences, while licensed medical use of established anesthetics (e.g., ketamine) continues in clinical settings. There is no publicly available evidence of national approvals or routine public reimbursement pathways for psychedelic medicines (psilocybin, MDMA, esketamine, DMT, etc.), and access outside authorized clinical research or established medical practice is effectively prohibited.